Home

Lipella Pharmaceuticals Inc. - Common Stock (LIPO)

2.7100
+0.0400 (1.50%)

Lipella Pharmaceuticals Inc. is a biopharmaceutical company focused on developing innovative therapies for urological conditions, particularly those affecting the bladder

The company is engaged in advancing its proprietary drug candidates through clinical trials, aiming to address unmet medical needs in the treatment of bladder diseases such as interstitial cystitis and overactive bladder. By leveraging advanced drug delivery technologies and focusing on targeted treatment approaches, Lipella seeks to improve patient outcomes and enhance the quality of life for individuals suffering from these debilitating conditions.

SummaryNewsPress ReleasesChartHistoricalFAQ
Spartan Capital Securities, LLC Serves as Sole Placement Agent in Lipella Pharmaceuticals Inc.’s $875,500 Private Placement
New York, NY, Jan. 10, 2025 (GLOBE NEWSWIRE) --  Spartan Capital Securities, LLC, a premier investment banking firm, is pleased to announce the successful completion of two private placements for Lipella Pharmaceuticals Inc. (Nasdaq: LIPO). Spartan Capital Securities, LLC acted as the sole placement agent in these private offerings of Series B non-voting convertible preferred stock of Lipella Pharmaceuticals Inc., raising an aggregate total of $875,500 through the transactions.
By Spartan Capital Securities, LLC · Via GlobeNewswire · January 10, 2025
Rising Number of Studies to Develop Novel Therapies For Pancreatic Ductal Adenocarcinoma (PDAC) Intensely Increasing
EQNX::TICKER_START (NASDAQONCY),(TSX:ONC),NASDAQ:CRDFNASDAQCRDF)(NYSE:LLYNYSELLY,(NYSE:ABBVNYSE),(NASDAQ:LIPOLIPO) EQNX::TICKER_END
Via FinancialNewsMedia · October 23, 2023
Lipella Pharmaceuticals to Present at the Fall Foliage MicroCap Rodeo Conference
PITTSBURGH, PA / ACCESSWIRE / October 23, 2023 / Lipella Pharmaceuticals Inc. (NASDAQLIPO) ("Lipella," "our, "us" or the "Company"), a clinical-stage biotechnology company addressing serious diseases with significant unmet need, will present at the 2023 virtual Fall Foliage MicroCap Rodeo Conference to be held from October 24th - 27th.
Via ACCESSWIRE · October 23, 2023
Lipella Pharmaceuticals: Addressing Significant Unmet Need for Cancer Survivors, Delivering Long Term Value for Shareholders
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via NewMediaWire · June 13, 2023